ASAM is committed to improving access to high-quality, evidence-based addiction prevention and treatment through our national advocacy efforts.

 

National Advocacy

Working closely with lawmakers on Capitol Hill and leaders in the Administration, we advocate for policies that promote a stronger addiction treatment workforce, standardize the delivery of individualized addiction treatment, and ensure equitable access and coverage for comprehensive, high-quality addiction care.

advocacy-webpage-graphics-teach-it

TEACH addiction medicine by expanding and strengthening our workforce and dispelling stigma.

0. Advocacy Webpage Graphics Standardize It
STANDARDIZE the delivery of individualized addiction treatment so that more patients receive high-quality, evidence-based care.
0. Advocacy Webpage Graphics Cover It
COVER addiction medicine in a way that expands patient access to comprehensive, high-quality addiction care.
s1
Other Policy Areas include a wide range prevention efforts and research of substance-related problems.

ASAM Board Member Dr. Stephen Taylor Participates in Panel Discussion of the Nation's Addiction Crisis

by | Aug 07, 2020

 

On August 7, ASAM board member Dr. Stephen M. Taylor, AMA’s immediate past president Dr. Patrice A. Harris, and Dr. Charles Reznikoff discussed the nation’s drug overdose crisis and COVID-19. The conversation covered a range of topics, including the AMA Opioid Task Force’s recently published 2020 Drug Overdose Report.


Specifically, the panel members examined the rising number of overdoses in the country even as clinicians have dramatically curtailed their opioid prescribing. Drs. Harris and Taylor stressed that those suffering from addiction have increasingly begun using substances other than opioids. Dr. Taylor noted healthcare systems must address increasing overdoses across the country as an addiction issue, instead of trying to combat the individual substances that those suffering from addiction choose to use at any one time. The conversation also focused on the social determinants of addiction, as well as the importance of distributing naloxone, treating incarcerated and newly released populations, and working with third party payers to expand access to addiction treatment.

 

 

Watch the discussion here.

 

Subscribe to the ASAM Advocate

Your source for timely, useful news briefings of top stories in addiction policy.